Integrative molecular and spatial analysis reveals evolutionary dynamics and tumor-immune interplay of in situ and invasive acral melanoma.
Liu H, Gao J, Feng M, Cheng J, Tang Y, Cao Q, Zhao Z, Meng Z, Zhang J, Zhang G, Zhang C, Zhao M, Yan Y, Wang Y, Xue R, Zhang N, Li H.
Cancer Cell. 2024 Jun 10;42(6):1067-1085.e11. doi: 10.1016/j.ccell.2024.04.012. Epub 2024 May 16.
PMID:38759655
Clinical implication of PRAME immunohistochemistry in differentiating melanoma in situ and dysplastic nevus in non-acral nevus-associated melanoma in situ: An institutional experience and meta-analysis.
Bui CM, Vuong HG, Le MK, D'Angelo J, Mannava K, Smoller BR.
Clin Exp Dermatol. 2025 Feb 24;50(3):529-536. doi: 10.1093/ced/llae465.
PMID:39449583
Skin Cancer: Epidemiology, Screening and Clinical Features of Acral Lentiginous Melanoma (ALM), Melanoma In Situ (MIS), Nodular Melanoma (NM) and Superficial Spreading Melanoma (SSM).
Lu CT, Lin TL, Mukundan A, Karmakar R, Chandrasekar A, Chang WY, Wang HC.